-
A New Hope for Peanut Allergy Sufferers: FDA Grants Fast Track Designation to PVX108
Revolutionizing Peanut Allergy Treatment For millions of people living with a peanut allergy, even accidental exposure can cause life-threatening reactions. Recently, the biotechnology company Aravax reached a major milestone in the fight to change this reality. The U.S. Food and Drug Administration (FDA) has officially granted Fast Track designation to the company’s lead investigational product,…